TNGX Stock Analysis: Buy, Sell, or Hold?

TNGX - Tango Therapeutics, Inc.

PHARMACEUTICAL PREPARATIONS
$11.61
-0.06 (-0.51%) ▼
BUY
MODERATE Confidence
Last Updated: January 30, 2026
Earnings: Feb 26, 2026 25d

Get Alerted When TNGX Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.
100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading chart...

Loading historical data...

💡
Bottom Line:
💡 BUY OPPORTUNITY: TNGX shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.

In-depth Analysis How we analyze

Valuation Analysis: TNGX is currently trading at $11.61, which is considered fair relative to its 30-day fair value range of $9.04 to $12.15.

Technical Outlook: Technically, TNGX is in a strong uptrend. Immediate support is located at $11.00, while resistance sits at $13.46.

Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $13.62 (+16.8%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.

Quick Decision Summary

Current Position FAIR
Fair Price Range $9.04 - $12.15
Company Quality Score 61/100 (BUY)
Volume Confirmation HIGH
Confidence Score 72.1%

All Signals

  • NEUTRAL: Price in fair range
  • NEUTRAL: Mixed technical signals (55/100)
  • BULLISH: High volume confirmation
  • BULLISH: Trading below Wall St target ($13.62)

Fair Price Analysis

30-Day Fair Range $9.04 - $12.15
Current vs Fair Value FAIR

Support & Resistance Levels

Support Level $11.00
Resistance Level $13.46
Current Trend Strong Uptrend

Fundamental Context

Forward P/E (Next Year Est.) -9.02
Wall Street Target $13.63 (+16.8%)
Revenue Growth (YoY) 363.6%
Profit Margin -151.2%
Last updated: January 31, 2026 12:39 AM ET
Data refreshes hourly during market hours. Next update: 1:39 AM
🔥 Top Stocks Breaking Out Now
Ticker Score Recommendation Change %
Insider Activity (6 Months)
0
Buys
6
Sells
Net
INSIDERS SELLING
Recent Transactions
Rock Ventures Iv L.P. Th… SELL 500000 shares 2025-09-25
Rock Ventures Iv L.P. Th… SELL 363541 shares 2025-09-16
Rock Ventures Iv L.P. Th… SELL 86459 shares 2025-09-08

Top Rated Biotechnology Stocks

Top-rated stocks in Biotechnology by analyst ratings.

Stock Analyst Consensus Analyst Target Tradestie Score
VRTX
Vertex Pharmaceuticals I…
BUY
34 analysts
$500 62 BUY
XENE
Xenon Pharmaceuticals Inc
STRONG BUY
19 analysts
$56 59 HOLD
AXSM
Axsome Therapeutics Inc
STRONG BUY
19 analysts
$210 57 HOLD
RARE
Ultragenyx
STRONG BUY
20 analysts
$64 55 HOLD
INCY
Incyte Corporation
HOLD
27 analysts
$102 62 BUY

Advanced TNGX Option Strategies

Professional options setups generated by AI based on today's TNGX price and gamma walls.

Iron Condor Bull Call Bear Put Collar

More Analysis for TNGX

TNGX Technical Chart TNGX Price Prediction TNGX Earnings Date TNGX Investment Advisor TNGX Fair Price Analyzer TNGX Options Advisor TNGX Options Chain TNGX Options Analysis TNGX Competitors
Live Trades
From trading groups
Loading trades...
View All Live Trades See Trader Consensus & Signals